Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88

Aisling Dunne, Mikael Ejdebäck, Phumzile L. Ludidi, Luke O'neill, Nicholas J. Gay

Journal of Biological Chemistry · 2003 · 203 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

The Toll/interleukin 1 receptor (TIR) domain is a region found in the cytoplasmic tails of members of the Toll-like receptor/interleukin-1 receptor superfamily. The domain is essential for signaling and is also found in the adaptor proteins Mal (MyD88 adaptor-like) and MyD88, which function to couple activation of the receptor to downstream signaling components. Experimental structures of two Toll/interleukin 1 receptor domains reveal a α–β-fold similar to that of the bacterial chemotaxis protein CheY, and other evidence suggests that the adaptors can make heterotypic interactions with both the receptors and themselves. Here we show that the purified TIR domains of Mal and MyD88 can form stable heterodimers and also that Mal homodimers and oligomers are dissociated in the presence of ATP. To identify structural features that may contribute to the formation of signaling complexes, we produced models of the TIR domains from human Toll-like receptor 4 (TLR4), Mal, and MyD88. We found that although the overall fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in TLRs 2 and 4, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model of the interactions is supported by experimental data from glutathione S-transferase pull-downs and co-immunoprecipitations. Neither theoretical nor experimental data suggest a direct role for the conserved proline in the BB-loop in the association of TLR4, Mal, and MyD88. Finally we show a sequence relationship between the Drosophila protein Tube and Mal that may indicate a functional equivalence of these two adaptors in the Drosophila and vertebrate Toll pathways. The Toll/interleukin 1 receptor (TIR) domain is a region found in the cytoplasmic tails of members of the Toll-like receptor/interleukin-1 receptor superfamily. The domain is essential for signaling and is also found in the adaptor proteins Mal (MyD88 adaptor-like) and MyD88, which function to couple activation of the receptor to downstream signaling components. Experimental structures of two Toll/interleukin 1 receptor domains reveal a α–β-fold similar to that of the bacterial chemotaxis protein CheY, and other evidence suggests that the adaptors can make heterotypic interactions with both the receptors and themselves. Here we show that the purified TIR domains of Mal and MyD88 can form stable heterodimers and also that Mal homodimers and oligomers are dissociated in the presence of ATP. To identify structural features that may contribute to the formation of signaling complexes, we produced models of the TIR domains from human Toll-like receptor 4 (TLR4), Mal, and MyD88. We found that although the overall fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in TLRs 2 and 4, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model of the interactions is supported by experimental data from glutathione S-transferase pull-downs and co-immunoprecipitations. Neither theoretical nor experimental data suggest a direct role for the conserved proline in the BB-loop in the association of TLR4, Mal, and MyD88. Finally we show a sequence relationship between the Drosophila protein Tube and Mal that may indicate a functional equivalence of these two adaptors in the Drosophila and vertebrate Toll pathways. In humans, innate immune responses provide the first line of defense against invading bacterial pathogens. Pathogen-associated molecular patterns such as lipopolysaccharide (LPS) 1The abbreviations used are: LPS, lipopolysaccharide; TLR, Toll-like receptor; TIR, Toll/interleukin 1 receptor domain; Mal, MyD88 adaptor-like; HEK, human embryonic kidney; HA, hemagglutinin; GST, glutathione S-transferase; P/H, proline to histidine mutation. from Gram-negative bacteria are sensed by macrophages, and these cells respond by producing pro-inflammatory cytokines (e.g. interleukin 1), which provoke the acute phase response to infection (for review see Ref. 1Dunne, A., and O'Neill, L. A. (2003) Science's STKE http://stke.sciencemag.org/cgi/content/full/sigtrans;2003/171/re3.Google Scholar). In recent years, it has become clear that the human Toll-like receptors (TLRs) are required to mediate these responses. These molecules are single pass transmembrane receptors, and they are related to Drosophila Toll, a protein involved in dorso-ventral patterning and antifungal innate immunity in the fly (2Gay N.J. Keith F.J. Nature. 1991; 351: 355-356Crossref PubMed Scopus (457) Google Scholar, 3Belvin M.P. Anderson K.V. Annu. Rev. Cell. Dev. Bi. 1996; 12: 393-416Crossref PubMed Scopus (690) Google Scholar, 4Imler J.L. Hoffmann J.A. Trends Cell Biol. 2001; 11: 304-311Abstract Full Text Full Text PDF PubMed Scopus (355) Google Scholar). Drosophila Toll and TLRs all have ectodomains with characteristic blocks of leucine-rich repeats and a cytoplasmic signaling domain of ∼200 residues called the Toll/interleukin 1 receptor (TIR) domain. The family of Toll receptors appears to use common components in the post-receptor signaling pathway, resulting in the activation of the transcription factor NFκB (5Buchanan S.G.S. Gay N.J. Prog. Biophys. Mol. Biol. 1996; 65: 1-44Crossref PubMed Google Scholar, 6Rock F.L. Hardiman G. Timans J.C. Kastelein R.A. Bazan J.F. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 588-593Crossref PubMed Scopus (1457) Google Scholar). It is now well established that human TLR4 together with two other membrane proteins CD14 and MD2 are able to sense the presence of LPS and to establish the appropriate signaling response (7Triantafilou M. Triantafilou K. Trends Immunol. 2002; 23: 301-304Abstract Full Text Full Text PDF PubMed Scopus (599) Google Scholar). For example, strains of mice that are hyposensitive to LPS either lack or have inactivating mutations in TLR4 (8Poltorak A. He X.L. Smirnova I. Liu M.Y. Van Huffel C. Du X. Birdwell D. Alejos E. Silva M. Galanos C. Freudenberg M. Ricciardi-Castagnoli P. Layton B. Beutler B. Science. 1998; 282: 2085-2088Crossref PubMed Scopus (6473) Google Scholar). Activation of the receptor is thought to involve dimerization followed by recruitment of a post-receptor complex containing the adaptor MyD88 and the protein kinase IRAK (interleukin 1 receptor-associated kinase) (9Wesche H. Henzel W.J. Shillinglaw W. Li S. Cao Z.D. Immunity. 1997; 7: 837-847Abstract Full Text Full Text PDF PubMed Scopus (922) Google Scholar). MyD88 is a critical component in the pathway and is required by most if not all of the TLRs (10Kawai T. Adachi O. Ogawa T. Takeda K. Akira S. Immunity. 1999; 11: 115-122Abstract Full Text Full Text PDF PubMed Scopus (1735) Google Scholar). It is a modular protein with a TIR and protein interaction domain termed the death domain (11Hardiman G. Rock F.L. Balasubramanian S. Kastelein R.A. Bazan J.F. Oncogene. 1996; 13: 2467-2475PubMed Google Scholar). The TIR domain is thought to bind with that of the receptor, and the death domain appears to interact with the death domain found at the N terminus of IRAK. Although MyD88 is the principal transducer of TLR signaling, the TLR4 pathway appears to have evolved a second adaptor called Mal (MyD88 adaptor-like) or TIRAP (TIR adaptor protein) (12Fitzgerald K.A. Palsson-McDermott E.M. Bowie A.G. Jefferies C.A. Mansell A.S. Brady G. Brint E. Dunne A. Gray P. Harte M.T. McMurray D. Smith D.E. Sims J.E. Bird T.A. O'Neill L.A.J. Nature. 2001; 413: 78-83Crossref PubMed Scopus (1002) Google Scholar, 13Horng T. Barton G.M. Medzhitov R. Nat. Immunol. 2001; 2: 835-841Crossref PubMed Scopus (830) Google Scholar). Similar to MyD88, this protein has a TIR but it lacks a death domain. In Drosophila, a clear homologue of MyD88 is involved in the Toll-mediated innate immune responses (14Horng T. Medzhitov R. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 12654-12658Crossref PubMed Scopus (216) Google Scholar, 15Tauszig-Delamasure S. Bilak H. Capovilla M. Hoffmann J.A. Imler J.L. Nat. Immunol. 2002; 3: 91-97Crossref PubMed Scopus (239) Google Scholar). However, in dorso-ventral patterning, a different adaptor, Tube, is used. Similar to MyD88, this protein has an N-terminal death domain but it lacks an obvious TIR domain (16Letsou A. Alexander S. Orth K. Wasserman S.A. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 810-814Crossref PubMed Scopus (95) Google Scholar). There is now consistent biochemical evidence that activation of TLRs involves the recruitment of specific post-receptor signaling complexes. However, there is still only limited structural information regarding these complexes. In fact, the only structures solved to date are those of the isolated TIRs from TLRs 1 and 2 (17Xu Y.W. Tao X. Shen B.H. Horng T. Medzhitov R. Manley J.L. Tong L. Nature. 2000; 408: 111-115Crossref PubMed Scopus (233) Google Scholar). These molecules have an overall fold with a central five-stranded parallel β-sheet surrounded by five helices. The structures are related to the bacterial chemotaxis protein CheY, confirming a prediction made by Bazan et al., (6Rock F.L. Hardiman G. Timans J.C. Kastelein R.A. Bazan J.F. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 588-593Crossref PubMed Scopus (1457) Google Scholar, 18Simonovic M. Volz K. J. Biol. Chem. 2001; 276: 28637-28640Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). Most of the conserved residues in TIR domains are buried in the core of the fold, but some are solvent-exposed residues located on one face of the protomer. This may form an interaction surface to which MyD88 and Mal can bind in response to signaling. In fact, a loop termed the BB-loop connecting the second β-strand and second helix includes a proline residue that is changed to histidine in mice, which are hyporesponsive to LPS, and the corresponding change also abolishes the ability of TLR2 to interact with MyD88 in vitro (8Poltorak A. He X.L. Smirnova I. Liu M.Y. Van Huffel C. Du X. Birdwell D. Alejos E. Silva M. Galanos C. Freudenberg M. Ricciardi-Castagnoli P. Layton B. Beutler B. Science. 1998; 282: 2085-2088Crossref PubMed Scopus (6473) Google Scholar, 17Xu Y.W. Tao X. Shen B.H. Horng T. Medzhitov R. Manley J.L. Tong L. Nature. 2000; 408: 111-115Crossref PubMed Scopus (233) Google Scholar). In this paper, we have modeled the TIR domains of TLR4, MyD88, and Mal. Experimental data are provided to support results obtained from docking studies, and putative interaction motifs are identified with particular attention being paid to the conserved proline residue found within the BB-loop of the receptor and adaptor TIR domains. These structures suggest mechanisms by which binding and specificity are achieved by different combinations of TIRs during signaling We also report sequence similarities between Mal and the Drosophila adaptor Tube and the ATP-dependent dissociation of Mal dimers and oligomers. Modeling Studies—The sequences of target proteins were extracted from the protein sequence data banks. Sequence homologues were retrieved using PSI-BLAST and aligned using ClustalW. The resulting alignment was carefully studied and further adjusted manually using a UNIX-based sequence alignment editor, SEAVIEW. Percentage similarities between homologues were scored using MALFORM. Homologues with known three-dimensional structures were aligned using COMPARER (19Sali A. Blundell TL. J. Mol. Biol. 1990; 212: 403-428Crossref PubMed Scopus (481) Google Scholar) or FuGue (20Shi J. Blundell T.L. Mizuguchi K. J. Mol. Biol. 2001; 310: 243-257Crossref PubMed Scopus (1085) Google Scholar). The JOY annotation used in structure based sequence alignments has been described previously (21Mizuguchi K. Deane C.M. Blundell T.L. Johnson M.S. Overingon J.P. Bioinformatics. 1998; 14: 617-623Crossref PubMed Scopus (358) Google Scholar, 22Burke D.F. Deane C.M. Nagarajaram H.A. Campillo N. Martin-Martinez M. Mendes J. Molina F. Perry J. Reddy B.V.B. Soares C.M. Steward R.E. Williams M. Carrondo M.A. Blundell T.L. Mizuguchi K. Proteins. 1999; : 55-60Crossref PubMed Scopus (40) Google Scholar). The target sequence was then aligned to the structure based alignment using This alignment was such that or within conserved structure regions are by a structure was used to models for models with the of and of were was used to the of models R.A. J. Google Scholar, Proteins. 12: PubMed Scopus Google Scholar). regions with residue were further modeled using P. M. D. Blundell T. Proteins. PubMed Scopus Google Scholar, M. P. S. Blundell T. Proteins. PubMed Scopus Google Scholar). were further using or which use and potentials to for protein of between TLR4 and the adaptor Mal and were using and in The docking were at at and of at models were and the were Cell and cells were obtained from the for and were in with and 2 and at in a of cells were a from were at to The was a from Medzhitov of The was a from Mal from the was the for For bacterial Mal, MyD88, and the TIR domain of TLR4 were by using a and the and of mutations were using the the of the of the other were obtained from and of Mal and MyD88 and were and in bacterial was to and was with cells were and in were in the at and the were by at was by on and protein and cells were to with combinations of of as using to the cells were by the of of were on in containing 2 and 1 of were by for 2 at 4 with the appropriate which been to protein at 4 The immune were in by and then by were using the proteins to were as described and for 2 with the in the The were in and to and against the and were obtained from The against the was obtained from The was obtained from The against human TLR4 was a from Keith Modeling of TLR4, Mal, and MyD88 TIR evidence suggests that TIR domains from receptors and adaptors are to form complexes. To this we used the structures of the TIR domain from TLRs 1 and 2 (17Xu Y.W. Tao X. Shen B.H. Horng T. Medzhitov R. Manley J.L. Tong L. Nature. 2000; 408: 111-115Crossref PubMed Scopus (233) Google Scholar) to molecular models for TLR4, Mal, and MyD88 TIR domains. alignments of experimental structures to target sequences by and COMPARER were used by for not The loop regions were using P. M. D. Blundell T. Proteins. PubMed Scopus Google Scholar, M. P. S. Blundell T. Proteins. PubMed Scopus Google Scholar). using and that the domains were modeled with structural surface of the experimental structure of TLRs 1 and 2 and the models of TLR4, Mal, and MyD88 are in 1 to show the This surface has a of conserved solvent-exposed residues the critical residue in the from this the electrostatic surface potentials are quite suggesting the of electrostatic The regions on the and of the BB-loop are the most For example, in TLR4, the is the corresponding region in Mal is characteristic of Mal that it from TLR4 and MyD88 is the lack of in a sequence at the of the TIR Ref. K.A. Palsson-McDermott E.M. Bowie A.G. Jefferies C.A. Mansell A.S. Brady G. Brint E. Dunne A. Gray P. Harte M.T. McMurray D. Smith D.E. Sims J.E. Bird T.A. O'Neill L.A.J. Nature. 2001; 413: 78-83Crossref PubMed Scopus (1002) Google Scholar). This region is located at the of the models and in Mal results in a electrostatic surface TLR4, Mal, and MyD88 are able to make heterotypic interactions with other and these surface may indicate binding specificity is achieved in the post-receptor In an to the interaction surface for TLR4 with Mal and we the adaptor proteins the TLR4 model using E. I. M. C. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, PubMed Scopus Google Scholar, C.A. Sci. 2002; 11: PubMed Scopus Google Scholar). docking was on the of and of the heterotypic of TLR4 with Mal and MyD88 are in this suggests non-overlapping binding on TLR4 for Mal and MyD88. Mal is predicted to and with the region of TLR4 on This region on TLR4 one of the BB-loop and the helix and to the region in MyD88 is predicted to bind with a surface by and to the on TLR4, which is located on the other of the receptor, Docking studies with the experimental structure of TLR2 suggest that both adaptors couple to the surface on this receptor In this is from that with TLR4 with the BB-loop of TLR2 a of between the two of the LPS on studies are with those described and also the BB-loop of TLR4 as an surface T. M. G. Mol. Cell. Biol. 23: PubMed Scopus Google Scholar). within this loop are critical for TLR4 signaling as by the mice, which are to LPS of an inactivating proline to histidine at of the corresponding residue in human TLR4 also the receptor and is thought to complex This is based on interaction studies with human TLR2 in which the adaptor to with the receptor (17Xu Y.W. Tao X. Shen B.H. Horng T. Medzhitov R. Manley J.L. Tong L. Nature. 2000; 408: 111-115Crossref PubMed Scopus (233) Google Scholar). to the not we similar to this is in the in a and the TLR4 the ability to bind to MyD88 in both and the and of TLR4 were also found to bind to Mal in and This from previously (12Fitzgerald K.A. Palsson-McDermott E.M. Bowie A.G. Jefferies C.A. Mansell A.S. Brady G. Brint E. Dunne A. Gray P. Harte M.T. McMurray D. Smith D.E. Sims J.E. Bird T.A. O'Neill L.A.J. Nature. 2001; 413: 78-83Crossref PubMed Scopus (1002) Google Scholar, 13Horng T. Barton G.M. Medzhitov R. Nat. Immunol. 2001; 2: 835-841Crossref PubMed Scopus (830) Google Scholar). a direct interaction was between and TLR4 and Mal the purified proteins were in corresponding proline residue is also found in the of Mal and MyD88. we the ability of of the adaptors to bind to in 4, a and the MyD88 has on and is consistent with model in which the BB-loop of MyD88 not form a of with the receptor TIR domain. It was previously that the Mal to bind to TLR4 T. Barton G.M. Medzhitov R. Nat. Immunol. 2001; 2: 835-841Crossref PubMed Scopus (830) Google in an interaction was between the two proteins in and this is consistent with model in which the BB-loop of Mal is from the Mal and MyD88 docking that Mal and MyD88 TIRs interact with other at a third non-overlapping This an of the Mal and MyD88 with residues at the of the BB-loop and together with residues on the helix in Mal, and in MyD88 in To this interaction is we a of and Mal in E. cells The two proteins were purified by on a the proteins were by was to with Mal of in Mal on the association of Mal with or with MyD88 in and and of the corresponding proline residue in MyD88 not as in a only of the TIR domain of MyD88 was used in these to N-terminal interactions that may by the death domain of MyD88. ATP-dependent of Mal and some of the and heterotypic interactions described the TIR domains of Mal and MyD88 were in E. a of the Mal and MyD88 were by on This an by Mal. of cells were in either the presence or of 1 a to a that with The were then purified as described and by in Mal in well all of which of Mal Mal purified from as a single This was in and was not with corresponding MyD88 TIR domain not Sequence between Mal and the Drosophila adaptors and Tube are known to couple to the Drosophila receptor, is a direct of vertebrate MyD88, we Mal related to We an alignment between the two proteins using and found that the N-terminal sequence of Mal the TIR domain is similar to the of Tube to the death domain of in this region are conserved or These are also conserved in the Tube sequence from the related Drosophila A. Alexander S. Wasserman S.A. J. 12: PubMed Scopus Google Scholar). The of Tube is also aligned by with or in the The most conserved regions to the predicted in the TIR models and core it that the Tube terminus a of the consistent with role in activation and signaling by the Drosophila Toll The and docking studies suggest that there are on the receptor TIR domains for binding Mal and MyD88 and a third of binding for the formation of Neither of the predicted interactions of the adaptor TIR domains appears to involve the BB-loop region on TLR4, although that predicted for Mal is to In vitro that of a critical proline which at the of the BB-loop is not to recruitment of the adaptor This with the finding that of the corresponding residue in TLR2 abolishes the binding of MyD88. there are structural between the and TLR2 protein (17Xu Y.W. Tao X. Shen B.H. Horng T. Medzhitov R. Manley J.L. Tong L. Nature. 2000; 408: 111-115Crossref PubMed Scopus (233) Google and this is the with we the that MyD88 is to the receptor Mal the bind at a It may also the that of a single residue within the BB-loop is not to a recent report a of interaction on the TLR4 TIR domain that in both the and on TLR4 are critical for signaling T. M. G. Mol. Cell. Biol. 23: PubMed Scopus Google Scholar). In the a docking and not able to that a change on if the BB-loop is involved in it may a such as that the binding of factor to S. P. Science. 2002; PubMed Scopus Google Scholar). In this a loop in a and this of a In support of this a recent of a TLR2 TIR which a different to that in the that the BB-loop is X. Y.W. Tong L. Biophys. 2002; PubMed Scopus Google Scholar). The of the adaptors also not to form a of with either TLR4 or in both docking and experimental we the that the proteins are to the receptor complex by of interactions is required to the of these We have and purified Mal and MyD88 to We have that heterodimers of MyD88 and Mal can in a purified consistent with results using and (12Fitzgerald K.A. Palsson-McDermott E.M. Bowie A.G. Jefferies C.A. Mansell A.S. Brady G. Brint E. Dunne A. Gray P. Harte M.T. McMurray D. Smith D.E. Sims J.E. Bird T.A. O'Neill L.A.J. Nature. 2001; 413: 78-83Crossref PubMed Scopus (1002) Google Scholar). We have also that the Mal protein can in different This is also consistent with which the ability of Mal to form homodimers as well as heterodimers with MyD88. we that the Mal oligomers dissociated if they were in the presence of of ATP. The of this is it suggests that Mal can different and that can or these binding has been previously for TIR domains Sci. PubMed Scopus Google Scholar). In the is similar to that of CheY, a bacterial chemotaxis protein that is at an This in the the change in of a residue in the loop between the β-sheet and This the interaction of with the membrane and Volz K. P. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). the structural between and the it that the function of these signaling domains also involves by binding or suggests that the Mal protein is related to Tube, an adaptor for the Drosophila Toll it was thought that Tube was to establish signaling in the Drosophila Toll However, it is now clear that a direct homologue of vertebrate MyD88 is required in to Tube for both dorso-ventral patterning and for antifungal responses S. Bilak H. Capovilla M. Hoffmann J.A. Imler J.L. Nat. Immunol. 2002; 3: 91-97Crossref PubMed Scopus (239) Google Scholar, Bilak H. R. M. Imler J.L. Capovilla M. PubMed Scopus Google a of the functional between vertebrate Mal and MyD88. Tube has a death domain sequence at the and this can some of signaling by the Toll receptor A. Alexander S. Wasserman S.A. J. 12: PubMed Scopus Google Scholar). The identified is located at the N-terminal of Mal the TIR, a region with a of which a In to Tube, Mal not have a death domain and couple to the downstream signaling pathway in a from MyD88. The functional of Mal, Tube, and Drosophila and vertebrate MyD88 homologues suggest that the of Tube a role with that of a TIR and may a of this fold, which from sequence These studies to a by which TIR adaptors can in response to activation of the further of this the experimental of structures for receptor and adaptor TIR complexes. The of TLR signaling adaptors further to this and it is clear that in vitro studies are required to the by which TLRs complexes. We the and the and

References

30